πŸ‡ΊπŸ‡Έ FDA
Patent

US 12005127

DNA-PK inhibitors

granted A61KA61K48/0066A61K48/0075

Quick answer

US patent 12005127 (DNA-PK inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
48
CPC classes
A61K, A61K48/0066, A61K48/0075, A61P, A61P35/00